Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
ConditionPulmonary Artery Stenosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 21
SponsorCordis US Corp.
About this trial
The purpose of the clinical investigation is to characterize clinical outcomes and to assess the real-world use of the commercial PALMAZ MULLINS XD™ Pulmonary Stent.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- PALMAZ MULLINS XD™ Pulmonary Stent
Treatment groups
75 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Cordis US Corp.
Lead sponsor
Congenital Cardiovascular Interventional Study Consortium (CCISC)
Collaborator
Source ClinicalTrials.gov